Viking Therapeutics (VKTX.US) weight loss drug delivers good news: dosing frequency halved while maintaining 97% weight reduction, stock price surged nearly 50% in pre-market trading.

智通财经2026/09/22 13:06

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

According to Zhitong Finance APP, Viking Therapeutics (VKTX.US) surged nearly 50% in pre-market trading on Tuesday after the biotechnology company announced that its experimental obesity drug VK2735 helped patients maintain most of their weight loss results even when the dosing frequency was reduced from once a week to once every two weeks.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Viking Therapeutics (VKTX.US) weight loss drug delivers good news: dosing frequency halved while maintaining 97% weight reduction, stock price surged nearly 50% in pre-market trading.

You may also like

Crypto prices